132 related articles for article (PubMed ID: 6197152)
1. Myelin basic protein: a component of circulating immune complexes in multiple sclerosis.
Dasgupta MK; Catz I; Warren KG; McPherson TA; Dossetor JB; Carnegie PR
Can J Neurol Sci; 1983 Nov; 10(4):239-43. PubMed ID: 6197152
[TBL] [Abstract][Full Text] [Related]
2. Identification of myelin basic protein (MBP) in circulating immune complexes (CIC) from some multiple sclerosis (MS) patients.
Dasgupta MK; McPherson TA; Catz I; Warren KG; Dossetor JB; Carnegie PR
Prog Clin Biol Res; 1984; 146():353-8. PubMed ID: 6201906
[No Abstract] [Full Text] [Related]
3. Identification of myelin basic proteins in circulating immune complexes associated with lepromatous leprosy.
Córsico B; Croce MV; Mukherjee R; Segal-Eiras A
Clin Immunol Immunopathol; 1994 Apr; 71(1):38-43. PubMed ID: 7511083
[TBL] [Abstract][Full Text] [Related]
4. Seric immune complexes in multiple sclerosis do not contain MBP epitopes.
Geffard M; Boullerne A; Brochet B
Brain Res Bull; 1993; 30(3-4):365-8. PubMed ID: 7681353
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients.
Brokstad KA; Page M; Nyland H; Haaheim LR
Acta Neurol Scand; 1994 Jun; 89(6):407-11. PubMed ID: 7526591
[TBL] [Abstract][Full Text] [Related]
6. Endogenous myelin basic protein-serum factors (MBP-SFs) and anti-MBP antibodies in humans. Occurrence in sera of clinically well subjects and patients with multiple sclerosis.
Paterson PY; Day ED; Whitacre CC; Berenberg RA; Harter DH
J Neurol Sci; 1981 Oct; 52(1):37-51. PubMed ID: 6170739
[TBL] [Abstract][Full Text] [Related]
7. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions.
O'Connor KC; Chitnis T; Griffin DE; Piyasirisilp S; Bar-Or A; Khoury S; Wucherpfennig KW; Hafler DA
J Neuroimmunol; 2003 Mar; 136(1-2):140-8. PubMed ID: 12620653
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal anti-myelin basic protein antibody production in Chinese patients with multiple sclerosis.
Tsai YL; Wang CR; Chiu HC; Chuang CY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1990 Nov; 23(4):284-90. PubMed ID: 1713143
[TBL] [Abstract][Full Text] [Related]
9. Detection of circulating immune complexes with a Raji cell enzyme immunoassay.
Rote NS; Caudle MR
J Immunol Methods; 1983; 56(1):33-42. PubMed ID: 6827090
[TBL] [Abstract][Full Text] [Related]
10. CSF antibodies to myelin basic protein and oligodendrocytes in multiple sclerosis and other neurological diseases.
Górny MK; Wróblewska Z; Pleasure D; Miller SL; Wajgt A; Koprowski H
Acta Neurol Scand; 1983 Jun; 67(6):338-47. PubMed ID: 6193672
[TBL] [Abstract][Full Text] [Related]
11. IgG reactivity against citrullinated myelin basic protein in multiple sclerosis.
de Seze J; Dubucquoi S; Lefranc D; Virecoulon F; Nuez I; Dutoit V; Vermersch P; Prin L
J Neuroimmunol; 2001 Jul; 117(1-2):149-55. PubMed ID: 11431015
[TBL] [Abstract][Full Text] [Related]
12. The pathogenesis and therapy of multiple sclerosis is based upon the requirement of a combination of myelin antigens for autoimmune demyelination.
Raine CS; Traugott U
J Neuroimmunol; 1982 Jan; 2(1):83-91. PubMed ID: 6185537
[TBL] [Abstract][Full Text] [Related]
13. CSF immune complexes in multiple sclerosis.
Coyle PK
Neurology; 1985 Mar; 35(3):429-32. PubMed ID: 2579355
[TBL] [Abstract][Full Text] [Related]
14. Components in multiple sclerosis cerebrospinal fluid that are detected by radioimmunoassay for myelin basic protein.
Carson JH; Barbarese E; Braun PE; McPherson TA
Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1976-8. PubMed ID: 77020
[TBL] [Abstract][Full Text] [Related]
15. Are anti-brain antibodies in multiple sclerosis directed to myelin basic protein? Studies employing the Shiverer mouse mutant.
Ryberg B; Jacque C
Acta Neurol Scand; 1986 Mar; 73(3):247-52. PubMed ID: 2424259
[TBL] [Abstract][Full Text] [Related]
16. Mild encephalitogenic activity of basic protein--acidic lipid complex from myelin and detection of immune complexes in experimental allergic encephalomyelitis.
Koh CS; Tsukada N; Yanagisawa N; Kunishita T; Uemura K; Taketomi T
J Neuroimmunol; 1981 Mar; 1(1):69-80. PubMed ID: 6173397
[TBL] [Abstract][Full Text] [Related]
17. Circulating antibody to myelin basic protein in relapsing-remitting multiple sclerosis? A comparative group and sequential study by radioimmunoassay.
Biggins JA; Taylor A; Caspary EA
J Neurol Neurosurg Psychiatry; 1978 Dec; 41(12):1131-4. PubMed ID: 83354
[TBL] [Abstract][Full Text] [Related]
18. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
[TBL] [Abstract][Full Text] [Related]
19. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.
Belogurov AA; Kurkova IN; Friboulet A; Thomas D; Misikov VK; Zakharova MY; Suchkov SV; Kotov SV; Alehin AI; Avalle B; Souslova EA; Morse HC; Gabibov AG; Ponomarenko NA
J Immunol; 2008 Jan; 180(2):1258-67. PubMed ID: 18178866
[TBL] [Abstract][Full Text] [Related]
20. CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis.
Panitch HS; Hooper CJ; Johnson KP
Arch Neurol; 1980 Apr; 37(4):206-9. PubMed ID: 6153890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
